Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 17Leukemia, Lymphocytic, Chronic, B-Cell 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Hodgkin Disease 15Multiple Myeloma 12Lymphoma, Non-Hodgkin 11Myelodysplastic Syndromes 10Lymphoma, Mantle-Cell 10Myeloproliferative Disorders 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Chronic-Phase 9Waldenstrom Macroglobulinemia 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Prolymphocytic 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Anemia, Refractory, with Excess of Blasts 6Leukemia 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Leukemia, Prolymphocytic, T-Cell 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Blast Crisis 4

Interventions

aldesleukin 9Interleukin-2 9Nivolumab 7fludarabine phosphate 6Dacarbazine 6Cyclophosphamide 6fludarabine 5Temozolomide 4Ipilimumab 4Fluorouracil 4montanide ISA 51 3Surveys and Questionnaires 3Semaxinib 3Radiotherapy 3Radiation 3Mohs Surgery 3Educational Status 3Cisplatin 3Allovectin-7 3zanolimumab 2talabostat 2sonidegib 2poly ICLC 2binimetinib 2Whole-Body Irradiation 2Vinblastine 2Vemurafenib 2Tacrolimus 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Skin Neoplasms × Cyclosporins × Clear all
NCT00133887 2025-12-26

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Hospices Civils de Lyon

Phase 3 Completed
77 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡